Moat Ross

Track

Insider profile

Moat Ross's trades of Kiniksa Pharmaceuticals Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
274.87
Quantity 90,871
Value US$4,586,326
Transaction date
Proposed sale
Price
48.58
Quantity 2,367
Value US$114,989
Transaction date
Proposed sale
Price
35.31
Quantity 3,523
Value US$124,397
Transaction date
Proposed sale
Price
29.02
Quantity 27,594
Value US$800,914
Transaction date
Proposed sale
Price
28.00
Quantity 6,272
Value US$175,646
Transaction date
Proposed sale
Price
28.01
Quantity 3,850
Value US$107,829
Transaction date
Proposed sale
Price
28.02
Quantity 23,234
Value US$650,949
Transaction date
Proposed sale
Price
25.21
Quantity 64,035
Value US$1,614,580
Transaction date
Proposed sale
Price
26.12
Quantity 68,506
Value US$1,789,288
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-13 2026-04-09
PlS Planned sale
57,241 -9.1%
338.55
US$1,109,739 		57,241 -9.1% 338.55 US$1,109,739
2026-04-09 2026-04-09
PrS Proposed sale
90,871
274.87
US$4,586,326 		90,871 274.87 US$4,586,326
2026-04-08 2026-04-06
PlS Planned sale
16,966 -28.7%
139.35
US$2,254,502 		16,966 -28.7% 139.35 US$2,254,502
2026-04-06 2026-04-06
PrS Proposed sale
2,367
48.58
US$114,989 		2,367 48.58 US$114,989
2025-09-08 2025-09-04
PlS Planned sale
3,523 -27.2%
35.31
US$124,397 		3,523 -27.2% 35.31 US$124,397
2025-09-04 2025-09-04
PrS Proposed sale
3,523
35.31
US$124,397 		3,523 35.31 US$124,397
2025-06-05 2025-06-03
PlS Planned sale
27,594 -74.6%
29.02
US$800,778 		27,594 -74.6% 29.02 US$800,778
2025-06-03 2025-06-03
PrS Proposed sale
27,594
29.02
US$800,914 		27,594 29.02 US$800,914
2025-05-05 2025-05-05
PrS Proposed sale
6,272
28.00
US$175,646 		6,272 28.00 US$175,646
2025-05-05 2025-05-05
PlS Planned sale
6,272 -40.0%
28.00
US$175,616 		6,272 -40.0% 28.00 US$175,616
2025-05-05 2025-05-02
PlS Planned sale
3,850 -29.0%
28.00
US$107,800 		3,850 -29.0% 28.00 US$107,800
2025-05-02 2025-05-02
PrS Proposed sale
3,850
28.01
US$107,829 		3,850 28.01 US$107,829
2025-05-01 2025-05-01
PrS Proposed sale
23,234
28.02
US$650,949 		23,234 28.02 US$650,949
2025-05-01 2025-05-01
PlS Planned sale
23,234 -71.2%
28.02
US$651,017 		23,234 -71.2% 28.02 US$651,017
2025-05-01 2025-04-29
PlS Planned sale
64,035 -87.2%
25.21
US$1,614,322 		64,035 -87.2% 25.21 US$1,614,322
2025-04-29 2025-04-29
PrS Proposed sale
64,035
25.21
US$1,614,580 		64,035 25.21 US$1,614,580
2025-04-23 2025-04-21
PlS Planned sale
18,259 -66.0%
20.29
US$370,475 		18,259 -66.0% 20.29 US$370,475
2025-04-21 2025-04-21
PrS Proposed sale
18,259
20.29
US$370,422 		18,259 20.29 US$370,422
2024-09-04 2024-09-03
PlS Planned sale
1,160 -5.1%
27.12
US$31,459 		1,160 -5.1% 27.12 US$31,459
2024-09-04 2024-09-03
PlS Planned sale
67,346 -74.6%
26.10
US$1,757,731 		67,346 -74.6% 26.10 US$1,757,731
2024-09-03 2024-09-03
PrS Proposed sale
68,506
26.12
US$1,789,288 		68,506 26.12 US$1,789,288